World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
21735
World Ranking
16747
National Ranking
8400

Jack L. Arbiser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jack L. Arbiser sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jack L. Arbiser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jack L. Arbiser sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jack L. Arbiser is affiliated with Emory University in the United States. Their research spans multiple disciplines, primarily within Medicine and Biochemistry, Genetics and Molecular Biology. Within these broad areas, their work is notably focused on subfields such as Molecular Biology, Rehabilitation, Dermatology, Immunology, and Oncology.

Their scholarly output includes numerous publications in recognized scientific venues. Among these, the journals with the highest number of their contributions include Cancers, JAAD Case Reports, Cells, International Journal of Molecular Sciences, and Scientific Reports.

Jack L. Arbiser's recent published papers cover a range of topics related to molecular mechanisms, pharmacology, and dermatological conditions. Selected recent articles are:

  • "Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties," 2023, Cells
  • "Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol," 2020, Molecular Oncology
  • "Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1," 2020, Antioxidants and Redox Signaling
  • "Early Detection and Prognostic Assessment of Cutaneous Melanoma," 2023, JAMA Dermatology
  • "Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells," 2021, International Journal of Molecular Sciences

The scientist has collaborated extensively with several frequent coauthors. Notable collaborators include Christina Huang (11 joint publications), Justin Elsey (8 joint publications), Rakan Radi (5 joint publications), Maiko Sasaki (4 joint publications), and Paola Baker (3 joint publications).

Research themes in their work are diverse and intersect several areas:

  • Magnolia and Illicium research
  • Dermatology and Skin Diseases
  • Histone Deacetylase Inhibitors Research
  • Pharmacological Effects of Natural Compounds
  • Allergic Rhinitis and Sensitization
  • Melanoma and MAPK Pathways
  • Autophagy in Disease and Therapy

Best Publications

  • Curcumin is an in vivo inhibitor of angiogenesis.

    Jack L. Arbiser;Jack L. Arbiser;Nancy Klauber;Richard Rohan;Robert Van Leeuwen

  • Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

    Jack L. Arbiser;Marsha A. Moses;Cecilia A. Fernandez;Neil Ghiso

  • Reactive oxygen generated by Nox1 triggers the angiogenic switch

    Jack L. Arbiser;John Petros;Robert Klafter;Baskaran Govindajaran

  • Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.

    M. B. Goldring;J. R. Birkhead;Lii-Fang Suen;Rina Yamin

  • Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.

    J M Friedman;Jack Arbiser;Jonathan A Epstein;David H Gutmann

  • Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

    Xianhe Bai;Francesca Cerimele;Masuko Ushio-Fukai;Muhammad Waqas

  • Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair

    Brett A. Shook;Renee R. Wasko;Guillermo C. Rivera-Gonzalez;Emilio Salazar-Gatzimas

  • Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3

    Vinodkumar B. Pillai;Sadhana Samant;Nagalingam R. Sundaresan;Hariharasundaram Raghuraman

  • The generation of endostatin is mediated by elastase.

    Wei Wen;Marsha A. Moses;Dmitri Wiederschain;Jack L. Arbiser

  • Mitogen-actived protein kinase activation is an early event in melanoma progression.

    Cynthia Cohen;Angel Zavala-Pompa;Judy H Sequeira;Mamoru Shoji

  • Designing a broad-spectrum integrative approach for cancer prevention and treatment

    Keith I. Block;Charlotte Gyllenhaal;Leroy Lowe;Amedeo Amedei

  • Overexpression of Akt converts radial growth melanoma to vertical growth melanoma

    Baskaran Govindarajan;Baskaran Govindarajan;James E. Sligh;James E. Sligh;Bethaney J. Vincent;Bethaney J. Vincent;Meiling Li;Meiling Li

  • Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent

    Levi E. Fried;Jack L. Arbiser

  • Current approaches to the treatment of metastatic brain tumours

    Taofeek K. Owonikoko;Jack Arbiser;Amelia Zelnak;Hui Kuo G. Shu

  • Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity

    Sabrina Diano;Zhong Wu Liu;Jin Kwon Jeong;Marcelo O. Dietrich;Marcelo O. Dietrich

  • A Key Role for NOX4 in Epithelial Cell Death During Development of Lung Fibrosis

    Stephanie Carnesecchi;Christine Deffert;Yves Donati;Olivier Basset

  • Forty-Year Journey of Angiogenesis Translational Research

    Yihai Cao;Jack Arbiser;Robert J. D’Amato;Patricia A. D’Amore

  • The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.

    Traci E. Battle;Jack Arbiser;David A. Frank

  • Clofazimine: A review of its medical uses and mechanisms of action

    Jack L Arbiser;Samuel L Moschella;Samuel L Moschella

  • Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis

    Kenji Ishitsuka;Teru Hideshima;Teru Hideshima;Teru Hideshima;Makoto Hamasaki;Makoto Hamasaki;Makoto Hamasaki;Noopur Raje;Noopur Raje;Noopur Raje

Frequent Co-Authors

Cynthia Cohen
Cynthia Cohen Emory University
Dong M. Shin
Dong M. Shin Emory University
Lawrence F. Brown
Lawrence F. Brown Beth Israel Deaconess Medical Center
Sharon W. Weiss
Sharon W. Weiss Emory University
Marsha A. Moses
Marsha A. Moses Boston Children's Hospital
Daniel J. Brat
Daniel J. Brat Northwestern University
David A. Frank
David A. Frank Harvard University
David E. Fisher
David E. Fisher Harvard University
Shi-Yong Sun
Shi-Yong Sun Emory University
David Goldsmith
David Goldsmith St Thomas' Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine but prefer alternative or flexible options, there are several online degree pathways that can help you move forward. Many healthcare roles now offer respected online programs that blend academic learning with the convenience of remote study.

For those aiming at healthcare leadership, check out the top online mha programs that are cahme accredited. These accredited programs prepare you for management roles in healthcare settings while ensuring high educational standards.

Registered nurses hoping to advance their qualifications will find rn to bsn online programs without clinicals especially appealing. These options allow working nurses to earn a bachelor’s degree without the traditional in-person clinical requirements.

For those seeking the highest clinical nursing credentials, consider dnp online programs that offer fast tracks to a Doctor of Nursing Practice. If your priority is manageable coursework, there are also easiest dnp programs designed to offer flexibility and accessibility.

These online degrees support a range of medical and healthcare careers, making it easier to progress or specialize without sacrificing your current commitments.

Best Scientists Citing Jack L. Arbiser

Trending Scientists

Recently Published Articles